methyl 4-bromo-1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate, 250mg

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea, 98.0%, 10mg

3-Methyl-2-vinylpyridine, 95% mix TBC as stabilizer, 1g

N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 250mg

(5-Methoxy-2-methyl-1H-indol-3-yl)acetic acid, 97.0%, 25g

TERT-BUTYL 3-(N-METHOXY-N-METHYLCARBAMOYL)PROPYLCARBAMATE, 95.0%, 500mg

1-(5-Bromo-2-methylpyridin-3-yl)ethanone, 95%, 1g

Indium, 99.99% 4N, foil, 100x100x0.1 mm, 5 pcs, plastic packaging.

1-(4-Fluorophenyl)-3-oxocyclobutanecarbonitrile, 98%, 250mg

3-Methoxy-3-methylbutyl acetate, 98+%, 25g

Mizoribine, 95%, 250mg

1-IODO-2-(TRIMETHYLSILYL)ACETYLENE, 95.0%, 1g

2-(3-Hydroxytetrahydrofuran-3-yl)acetic acid, 98%, 500mg